🇺🇸 FDA
Patent

US 10322129

Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same

granted A61KA61K31/519A61K9/0048

Quick answer

US patent 10322129 (Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same) held by O.D. Ocular Discovery Ltd. expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
O.D. Ocular Discovery Ltd.
Grant date
Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/519, A61K9/0048, A61P, A61P27/12